Curcumin is a potent bioactive compound of Curcuma longa. Curcumin comprises a broad spectrum of biological activities, including hepatoprotective, anticancer, antimicrobial, anti-inflammatory, antitumor, anti-oxidant, etc. However, its low aqueous solubility, rapid excretion, and poor bioavailability restricted its therapeutic uses. To resolve these issues, novel nano-systems have now been developed to increase the bioactivity and bioavailability of curcumin by lowering the particle size, altering the surface, and increasing the efficacy of its encapsulation with various nanocarriers. Nanotechnology-based treatments can broaden the outlook for individuals with critical conditions. This article explores curcumin-based nanoparticulate carrier systems that should be employed to overcome this natural ingredient's inherent limitations. These nanocarriers also provide physical and chemical stability by encapsulating the drug into the core or matrix of the lipids or polymers. Nanotechnologists developed curcumin-encapsulated various nanoparticulate systems, including solid lipidic nanoparticles, polymeric nanoparticles, nano-structured lipid carriers, polymer conjugates, etc., to improve curcumin bioavailability and boost the sustained release of curcumin to target cells.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612829666230613115447DOI Listing

Publication Analysis

Top Keywords

nanoparticulate carrier
8
carrier systems
8
curcumin
6
insights nanoparticulate
4
systems curcumin
4
curcumin clinical
4
clinical perspective
4
perspective management
4
management health
4
health issues
4

Similar Publications

PEG-PLGA nanoparticles deposited in and .

J Pharm Anal

December 2024

Institute of Infectious Disease and Infection Control, Jena University Hospital, Jena, 07747, Germany.

In our prior research, polymer nanoparticles (NPs) containing tobramycin displayed robust antibacterial efficacy against biofilm-embedded () and (. ) cells, critical pathogens in cystic fibrosis. In the current study, we investigated the deposition of a nanoparticulate carrier composed of poly(d,l-lactic--glycolic acid) (PLGA) and poly(ethylene glycol)--PLGA (PEG-PLGA) that was either covalently bonded with cyanine-5-amine (Cy5) or noncovalently bound with freely embedded cationic rhodamine B (RhB), which served as a drug surrogate.

View Article and Find Full Text PDF

The goal of this study is to assess the potential advantages of utilising methotrexate (MTH), and mangiferin (MFR), in nanoparticulate configuration which is transethosomes (TRS), which could result in increased stability and solubility, as well as improved infiltration into the arthritic tissues under investigation. The synthesised MTH-MFR-TRS demonstrated a particle size of 151.7 nm and a PDI of 0.

View Article and Find Full Text PDF

Ocular drug-delivery is one of the most challenging areas owing to nature of ocular tissues. Various nanoformulations have been designed and investigated for drug-delivery to achieve high drug bioavailability. The major focus of these preparations available in market is to utilize nanomaterial as drug-carrier only, with less focus on developing functional-nanomaterials, which is a key knowledge gap in the field.

View Article and Find Full Text PDF

Esterified Lignin Nanoparticles for Targeted Chemical Delivery in Plant Protection.

ACS Appl Mater Interfaces

January 2025

Department of Materials and Environmental Chemistry, Stockholm University, Svante Arrhenius väg 16C, 10691 Stockholm, Sweden.

There is a growing demand for biobased functional materials that can ensure targeted pesticide delivery and minimize active ingredient loss in the agricultural sector. In this work, we demonstrated the use of esterified lignin nanoparticles (ELNPs) as carriers and controlled-release agents of hydrophobic compounds. Curcumin was selected as a hydrophobic model compound and was incorporated during ELNP fabrication with entrapment efficiencies exceeding 95%.

View Article and Find Full Text PDF

Advances in dorzolamide hydrochloride delivery: harnessing nanotechnology for enhanced ocular drug delivery in glaucoma management.

Discov Nano

December 2024

The Novel Drug & Vaccine Delivery Systems Facility, Department of Chemistry and Biochemistry, Laurentian University, Sudbury, ON, P3E 2C6, Canada.

Article Synopsis
  • Dorzolamide hydrochloride (DRZ) is a medication used to lower eye pressure in glaucoma patients, but its effectiveness is limited by a short duration of action and the need for frequent use.
  • Recent advancements in drug delivery systems, such as cyclodextrin complexation and nanotechnology, aim to enhance the bioavailability and effectiveness of DRZ.
  • These innovative systems, including nanoparticle carriers and liposome formulations, provide sustained release and better eye penetration, potentially improving patient compliance and treatment outcomes compared to traditional methods.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!